CoChat

Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma

Open access

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Abstract

Glaucoma is a group of optic neuropathies associated with aging and sensitivity to intraocular pressure (IOP). Early progression involves retinal ganglion cell (RGC) axon dysfunction that precedes frank degeneration. Previously we demonstrated that p38 MAPK inhibition abates axonal dysfunction and slows degeneration in the inducible microbead occlusion model of glaucoma in rat. Here, we assessed the neuroprotective effect of topical eye delivery of the p38 MAPK inhibitor BIRB 796 in three models of glaucoma (microbead occlusion in rat and squirrel monkey and the genetic DBA/2 J mouse model) with distinct durations of IOP elevation. While BIRB 796 did not influence IOP, treatment over four weeks in rats prevented degradation of anterograde axonal transport to the superior colliculus and degeneration in the optic nerve. Treatment over months in the chronic DBA/2 J model and in the squirrel monkey model reduced expression and activation of p38 downstream targets in the retina and brain but did not rescue RGC axon transport or degeneration, suggesting the efficacy of BIRB 796 in preventing associated degeneration of the RGC projection depends on the duration of the experimental model. These results emphasize the importance of evaluating potential therapeutic compounds for neuroprotection in multiple models using elongated treatment paradigms for an accurate assessment of efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-65374-6

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Experimental timeline and schematic. (a) Experimental timelines for rat, mouse and squirrel monkey cohorts. Microbead injections (MOM injx, arrowheads), intravitreal injection of cholera toxin subunit B (CTB injx, perpendicular lines), baseline intraocular pressure measurements (IOPs, light gray bars) and treatment intraocular pressure measurements (IOPs, dark gray bars) were performed according to their position on the timelines. Treatment with vehicle or BIRB 796 is indicated by the bracketed line (|—|) and length of treatment (4 weeks, 24 weeks or 29 weeks). Scale: line indicates 1 week. (b) Experimental schematic for rat vehicle, BIRB-796, and naïve experimental groups showing which eyes received microbead or saline injection, which eyes received vehicle or BIRB 796 treatment, and which eyes received CTB injection. (c) Experimental schematic for DBA/2 J mouse vehicle and BIRB-796 experimental groups indicating eyes that received vehicle or BIRB 796 treatment, and eyes received CTB injection. (d) Experimental schematic for squirrel monkey (SM) vehicle and BIRB-796 experimental groups showing which eyes received microbead injection, which eyes received vehicle or BIRB 796 treatment, and which eyes received CTB injection.
Figure 1 Experimental timeline and schematic. (a) Experimental timelines for rat, mouse and squirrel monkey cohorts. Microbead injections (MOM injx, arrowheads), intravitreal injection of cholera toxin subunit B (CTB injx, perpendicular lines), baseline intraocular pressure measurements (IOPs, light gray bars) and treatment intraocular pressure measurements (IOPs, dark gray bars) were performed according to their position on the timelines. Treatment with vehicle or BIRB 796 is indicated by the bracketed line (|—|) and length of treatment (4 weeks, 24 weeks or 29 weeks). Scale: line indicates 1 week. (b) Experimental schematic for rat vehicle, BIRB-796, and naïve experimental groups showing which eyes received microbead or saline injection, which eyes received vehicle or BIRB 796 treatment, and which eyes received CTB injection. (c) Experimental schematic for DBA/2 J mouse vehicle and BIRB-796 experimental groups indicating eyes that received vehicle or BIRB 796 treatment, and eyes received CTB injection. (d) Experimental schematic for squirrel monkey (SM) vehicle and BIRB-796 experimental groups showing which eyes received microbead injection, which eyes received vehicle or BIRB 796 treatment, and which eyes received CTB injection.CC BY · PubMed Central
Figure 2 BIRB 796 protects anterograde transport in rats following IOP elevation. (a) Mean intraocular pressure (IOP) in rats following a single unilateral injection of microbeads into the anterior chamber (dark gray symbols). The fellow eye was injected with an equivalent volume of saline (light gray symbols). Arrowhead indicates microbead injection. (b) Bar graph showing mean IOP in naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat eyes. *p ≤ 0.01. (c) Confocal images of whole-mounted retinas showing RGC uptake and transport of CTB (green) in naïve, vehicle- and BIRB 796-treated rats. Scale: 30 μm. (d) Coronal sections (top row) through the superior colliculus (SC) following intravitreal injection of CTB (green) into naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat eyes. Transport deficits are indicated by dotted lines. OD: optic disc representation (arrows). Retinotopic maps (bottom row) reconstructed from serial sections of SC with optic disc indicated (circles). Density of the transported CTB signal ranges from 0% (blue) to 50% (green) to 100% (red). Medial (M) and rostral (R) orientations are indicated. Scale bars: 500 μm. (e) Bar graph showing mean level of intact transport to the SC from naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat eyes. *p = 0.00002; **p = 0.00007. Data expressed as mean ± SEM. Statistical comparisons made using one-way ANOVA and two-sided t-tests. n = 4 rats for naïve, 8 for vehicle, 9 for BIRB 796 groups (a,b); n = 8 SCs for naïve, vehicle-saline and vehicle-microbead and 9 SCs for BIRB 796-saline and BIRB 796-microbead groups (d,e).
Figure 2 BIRB 796 protects anterograde transport in rats following IOP elevation. (a) Mean intraocular pressure (IOP) in rats following a single unilateral injection of microbeads into the anterior chamber (dark gray symbols). The fellow eye was injected with an equivalent volume of saline (light gray symbols). Arrowhead indicates microbead injection. (b) Bar graph showing mean IOP in naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat eyes. *p ≤ 0.01. (c) Confocal images of whole-mounted retinas showing RGC uptake and transport of CTB (green) in naïve, vehicle- and BIRB 796-treated rats. Scale: 30 μm. (d) Coronal sections (top row) through the superior colliculus (SC) following intravitreal injection of CTB (green) into naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat eyes. Transport deficits are indicated by dotted lines. OD: optic disc representation (arrows). Retinotopic maps (bottom row) reconstructed from serial sections of SC with optic disc indicated (circles). Density of the transported CTB signal ranges from 0% (blue) to 50% (green) to 100% (red). Medial (M) and rostral (R) orientations are indicated. Scale bars: 500 μm. (e) Bar graph showing mean level of intact transport to the SC from naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat eyes. *p = 0.00002; **p = 0.00007. Data expressed as mean ± SEM. Statistical comparisons made using one-way ANOVA and two-sided t-tests. n = 4 rats for naïve, 8 for vehicle, 9 for BIRB 796 groups (a,b); n = 8 SCs for naïve, vehicle-saline and vehicle-microbead and 9 SCs for BIRB 796-saline and BIRB 796-microbead groups (d,e).CC BY · PubMed Central
Figure 3 BIRB 796 protects RGC axons in rat optic nerve following IOP elevation. (a) Representative image of rat optic nerve montage used to count RGC axons using AxonJ46. Scale: 100 μm. (b) Representative image from a naïve rat optic nerve montage. Scale: 20 μm. (c) Representative images from vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat optic nerve montages. Degenerating axon profiles (arrowheads) and glial hypertrophy (asterisk) are indicated. Scale: 20 μm. (d) Bar graph showing mean RGC axon number from naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat optic nerve. *p = 0.0002; **p = 0.01. Data expressed as mean ± SEM. Statistical comparisons made using one-way ANOVA and two-sided t-tests. n = 8 optic nerve montages for naïve, vehicle-saline and vehicle-microbead and 9 optic nerve montages for BIRB 796-saline and BIRB 796-microbead groups.
Figure 3 BIRB 796 protects RGC axons in rat optic nerve following IOP elevation. (a) Representative image of rat optic nerve montage used to count RGC axons using AxonJ46. Scale: 100 μm. (b) Representative image from a naïve rat optic nerve montage. Scale: 20 μm. (c) Representative images from vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat optic nerve montages. Degenerating axon profiles (arrowheads) and glial hypertrophy (asterisk) are indicated. Scale: 20 μm. (d) Bar graph showing mean RGC axon number from naïve, vehicle-saline, vehicle-microbead, BIRB 796-saline and BIRB 796-microbead rat optic nerve. *p = 0.0002; **p = 0.01. Data expressed as mean ± SEM. Statistical comparisons made using one-way ANOVA and two-sided t-tests. n = 8 optic nerve montages for naïve, vehicle-saline and vehicle-microbead and 9 optic nerve montages for BIRB 796-saline and BIRB 796-microbead groups.CC BY · PubMed Central
Figure 4 BIRB 796 and anterograde transport in DBA/2 J mice. (a) Mean intraocular pressure (IOP) in vehicle- and BIRB 796-treated DBA/2 J mice. Red dashed line indicates mean baseline IOP from all mice. *p ≤ 0.00002 versus baseline IOP. (b) Bar graph showing mean baseline IOP and treatment IOP for vehicle- and BIRB 796-treated DBA/2 J mice. *p ≤ 0.0005. (c) Confocal images of whole-mounted retinas showing RGC uptake and transport of CTB (green) in vehicle- and BIRB 796-treated DBA/2 J mice. Phosphorylated neurofilament-heavy (pNF-H; red) expression in RGC somas and axons is also shown. RGC somas (arrowheads) and axons (arrows) that lack CTB are found in both groups. Scale: 30 μm. (d) Coronal sections (top rows) of the SC following intravitreal injection of CTB (green) into eyes of vehicle- and BIRB 796-treated mice. Transport deficits are indicated by dotted lines. OD: optic disc representation (arrows). Retinotopic maps (bottom rows) reconstructed from serial sections of SC with optic disc gap indicated (circles). Density of the transported CTB signal ranges from 0% (blue) to 50% (green) to 100% (red). Medial (M) and rostral (R) orientations are indicated. Scale bars: 500 μm. (e) Scatter plot showing level of intact transport to the SC from vehicle- and BIRB 796-treated DBA/2 J mice. Thin black lines indicate mean ± SEM. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 20 mice per group (a and b); n = 28 SCs for vehicle-treated group and 30 SCs for BIRB 796-treated group (d and e).
Figure 4 BIRB 796 and anterograde transport in DBA/2 J mice. (a) Mean intraocular pressure (IOP) in vehicle- and BIRB 796-treated DBA/2 J mice. Red dashed line indicates mean baseline IOP from all mice. *p ≤ 0.00002 versus baseline IOP. (b) Bar graph showing mean baseline IOP and treatment IOP for vehicle- and BIRB 796-treated DBA/2 J mice. *p ≤ 0.0005. (c) Confocal images of whole-mounted retinas showing RGC uptake and transport of CTB (green) in vehicle- and BIRB 796-treated DBA/2 J mice. Phosphorylated neurofilament-heavy (pNF-H; red) expression in RGC somas and axons is also shown. RGC somas (arrowheads) and axons (arrows) that lack CTB are found in both groups. Scale: 30 μm. (d) Coronal sections (top rows) of the SC following intravitreal injection of CTB (green) into eyes of vehicle- and BIRB 796-treated mice. Transport deficits are indicated by dotted lines. OD: optic disc representation (arrows). Retinotopic maps (bottom rows) reconstructed from serial sections of SC with optic disc gap indicated (circles). Density of the transported CTB signal ranges from 0% (blue) to 50% (green) to 100% (red). Medial (M) and rostral (R) orientations are indicated. Scale bars: 500 μm. (e) Scatter plot showing level of intact transport to the SC from vehicle- and BIRB 796-treated DBA/2 J mice. Thin black lines indicate mean ± SEM. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 20 mice per group (a and b); n = 28 SCs for vehicle-treated group and 30 SCs for BIRB 796-treated group (d and e).CC BY · PubMed Central
Figure 5 BIRB 796 and RGC axons in DBA/2 J optic nerve. (a) Representative image of DBA/2 J mouse optic nerve montage used to count RGC axons using AxonJ46. Red line indicates optic nerve area as measured using Fiji45. Scale: 50 μm. (b) Representative image from a DBA/2J-Gpnmb+/SjJ (D2 Control) mouse optic nerve montage. Scale: 10 μm. (c) Representative images from vehicle- and BIRB 796-treated DBA/2 J mouse optic nerve montages. Degenerating axon profiles (arrowheads) and glial hypertrophy (asterisk) are indicated. Scale: 10 μm. (d) Scatter plot showing RGC axon number from vehicle- and BIRB 796-treated DBA/2 J mouse optic nerve. Thin black lines indicate mean ± SEM. Thick black dotted line indicates D2 Control RGC axon number for non-statistical comparison. (e) Scatter plot showing optic nerve area from vehicle- and BIRB 796-treated DBA mouse optic nerve. Thin black lines indicate mean ± SEM. Thick black dotted line indicates D2 Control RGC axon number for non-statistical comparison. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 8 optic nerve montages for D2 Control, 17 optic nerve montages for vehicle-treated and 18 optic nerve montages for BIRB 796-treated groups.
Figure 5 BIRB 796 and RGC axons in DBA/2 J optic nerve. (a) Representative image of DBA/2 J mouse optic nerve montage used to count RGC axons using AxonJ46. Red line indicates optic nerve area as measured using Fiji45. Scale: 50 μm. (b) Representative image from a DBA/2J-Gpnmb+/SjJ (D2 Control) mouse optic nerve montage. Scale: 10 μm. (c) Representative images from vehicle- and BIRB 796-treated DBA/2 J mouse optic nerve montages. Degenerating axon profiles (arrowheads) and glial hypertrophy (asterisk) are indicated. Scale: 10 μm. (d) Scatter plot showing RGC axon number from vehicle- and BIRB 796-treated DBA/2 J mouse optic nerve. Thin black lines indicate mean ± SEM. Thick black dotted line indicates D2 Control RGC axon number for non-statistical comparison. (e) Scatter plot showing optic nerve area from vehicle- and BIRB 796-treated DBA mouse optic nerve. Thin black lines indicate mean ± SEM. Thick black dotted line indicates D2 Control RGC axon number for non-statistical comparison. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 8 optic nerve montages for D2 Control, 17 optic nerve montages for vehicle-treated and 18 optic nerve montages for BIRB 796-treated groups.CC BY · PubMed Central
Figure 6 BIRB 796 modulates expression of p38-related injury targets in DBA/2 J mice. (a) Quantitative RT-PCR measurements of mRNA encoding Bcl2-associated X protein (Bax). *p = 0.01. (b) Quantitative RT-PCR measurements of mRNA encoding lipocalin-2 (Lcn2). *p = 0.0006. (c) Quantitative RT-PCR measurements of mRNA encoding ceruloplasmin (Cp). *p = 0.0003. (d) Quantitative RT-PCR measurements of mRNA encoding interleukin-1β (Il1β). *p = 0.007. (e) Confocal images from vehicle- and BIRB 796-treated DBA/2 J superior colliculus showing immunolabeling for BAX (red). Scale bars: 30 μm. (f) Confocal images from vehicle- and BIRB 796-treated DBA/2 J superior colliculus showing immunolabeling for lipocalin-2 (LCN2, red). (g) Confocal images from vehicle- and BIRB 796-treated DBA/2 J retina showing immunolabeling for ceruloplasmin (CP, red). Dotted lines indicate retinal region where label was quantified. NFL: nerve fiber layer; GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (h) Confocal images from vehicle- and BIRB 796-treated DBA/2 J retina showing immunolabeling for interleukin-1β (IL1β, red). Dotted lines indicate retinal region where label was quantified. NFL: nerve fiber layer; GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (i) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J superior colliculus immunolabeled for BAX. Thin black lines indicate mean ± SEM. *p = 0.02. (j) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J superior colliculus immunolabeled for lipocalin-2. Thin black lines indicate mean ± SEM. *p = 0.001. (k) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J retina immunolabeled for ceruloplasmin. Thin black lines indicate mean ± SEM. (l) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J retina immunolabeled for interleukin-1β. Thin black lines indicate mean ± SEM. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 5 vehicle-treated and 4 BIRB 796-treated retinas, 8 vehicle-treated and 7 BIRB 796-treated SCs (a); n = 4 vehicle-treated and 5 BIRB 796-treated retinas, 7 vehicle-treated and 8 BIRB 796-treated SCs (b); n = 4 vehicle-treated and 5 BIRB 796-treated retinas, 8 vehicle-treated and 8 BIRB 796-treated SCs (c); n = 4 vehicle-treated retinas, BIRB 796-treated retinas, vehicle-treated SCs and BIRB 796-treated SCs (d); n = 12 vehicle-treated and 12 BIRB 796-treated SCs (e,i); n = 12 vehicle-treated and 11 BIRB 796-treated SCs (f,j); n = 7 vehicle-treated and 7 BIRB 796-treated retinas (g,k); n = 7 vehicle-treated and 8 BIRB 796-treated retinas (h,l).
Figure 6 BIRB 796 modulates expression of p38-related injury targets in DBA/2 J mice. (a) Quantitative RT-PCR measurements of mRNA encoding Bcl2-associated X protein (Bax). *p = 0.01. (b) Quantitative RT-PCR measurements of mRNA encoding lipocalin-2 (Lcn2). *p = 0.0006. (c) Quantitative RT-PCR measurements of mRNA encoding ceruloplasmin (Cp). *p = 0.0003. (d) Quantitative RT-PCR measurements of mRNA encoding interleukin-1β (Il1β). *p = 0.007. (e) Confocal images from vehicle- and BIRB 796-treated DBA/2 J superior colliculus showing immunolabeling for BAX (red). Scale bars: 30 μm. (f) Confocal images from vehicle- and BIRB 796-treated DBA/2 J superior colliculus showing immunolabeling for lipocalin-2 (LCN2, red). (g) Confocal images from vehicle- and BIRB 796-treated DBA/2 J retina showing immunolabeling for ceruloplasmin (CP, red). Dotted lines indicate retinal region where label was quantified. NFL: nerve fiber layer; GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (h) Confocal images from vehicle- and BIRB 796-treated DBA/2 J retina showing immunolabeling for interleukin-1β (IL1β, red). Dotted lines indicate retinal region where label was quantified. NFL: nerve fiber layer; GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (i) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J superior colliculus immunolabeled for BAX. Thin black lines indicate mean ± SEM. *p = 0.02. (j) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J superior colliculus immunolabeled for lipocalin-2. Thin black lines indicate mean ± SEM. *p = 0.001. (k) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J retina immunolabeled for ceruloplasmin. Thin black lines indicate mean ± SEM. (l) Scatter plot showing percent area of vehicle- and BIRB 796-treated DBA/2 J retina immunolabeled for interleukin-1β. Thin black lines indicate mean ± SEM. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 5 vehicle-treated and 4 BIRB 796-treated retinas, 8 vehicle-treated and 7 BIRB 796-treated SCs (a); n = 4 vehicle-treated and 5 BIRB 796-treated retinas, 7 vehicle-treated and 8 BIRB 796-treated SCs (b); n = 4 vehicle-treated and 5 BIRB 796-treated retinas, 8 vehicle-treated and 8 BIRB 796-treated SCs (c); n = 4 vehicle-treated retinas, BIRB 796-treated retinas, vehicle-treated SCs and BIRB 796-treated SCs (d); n = 12 vehicle-treated and 12 BIRB 796-treated SCs (e,i); n = 12 vehicle-treated and 11 BIRB 796-treated SCs (f,j); n = 7 vehicle-treated and 7 BIRB 796-treated retinas (g,k); n = 7 vehicle-treated and 8 BIRB 796-treated retinas (h,l).CC BY · PubMed Central
Figure 7 BIRB 796 and anterograde transport in squirrel monkeys following IOP elevation. (a) Mean intraocular pressure (IOP) in squirrel monkeys (SMs) following bilateral injection of microbeads into the anterior chamber of vehicle- and BIRB 796-treated SMs. Arrowheads indicate microbead injections. Red dashed line indicates mean baseline IOP from all SMs. *p ≤ 0.016 versus baseline IOP. (b) Bar graph showing mean baseline IOP and treatment IOP for vehicle- and BIRB 796-treated SMs. *p ≤ 0.02. (c) Confocal images of whole-mounted retinas showing RGC uptake and transport of CTB (green in left eyes, red in right eyes) in vehicle- and BIRB 796-treated SMs. Phosphorylated neurofilament-heavy (pNF-H; blue) expression in RGC somas and axons is shown. Scale: 50 μm. (d) Coronal section of a lateral geniculate nucleus (LGN) from a saline-injected SM from a previous study39. CTB transported from the left eye (LE, green) and the right eye (RE, red) are shown. Scale: 500 μm. (e) Coronal sections of LGN from a vehicle-treated and a BIRB 796-treated SM. CTB transported from the left eye (LE, green) and the right eye (RE, red) are shown. Scale: 500 μm. (f) Scatter plot showing percent intact transport to the LGN from microbead-injected eyes from vehicle- and BIRB 796-treated SMs. Thin black lines indicate mean ± SEM. Thick black dotted line indicates transport to the LGN from saline-injected eyes (Saline) from a previous study for non-statistical comparison39. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 4 eyes per group (a,b); n = 4 LGNs for vehicle-treated group and 4 LGNs for BIRB 796-treated group (e,f).
Figure 7 BIRB 796 and anterograde transport in squirrel monkeys following IOP elevation. (a) Mean intraocular pressure (IOP) in squirrel monkeys (SMs) following bilateral injection of microbeads into the anterior chamber of vehicle- and BIRB 796-treated SMs. Arrowheads indicate microbead injections. Red dashed line indicates mean baseline IOP from all SMs. *p ≤ 0.016 versus baseline IOP. (b) Bar graph showing mean baseline IOP and treatment IOP for vehicle- and BIRB 796-treated SMs. *p ≤ 0.02. (c) Confocal images of whole-mounted retinas showing RGC uptake and transport of CTB (green in left eyes, red in right eyes) in vehicle- and BIRB 796-treated SMs. Phosphorylated neurofilament-heavy (pNF-H; blue) expression in RGC somas and axons is shown. Scale: 50 μm. (d) Coronal section of a lateral geniculate nucleus (LGN) from a saline-injected SM from a previous study39. CTB transported from the left eye (LE, green) and the right eye (RE, red) are shown. Scale: 500 μm. (e) Coronal sections of LGN from a vehicle-treated and a BIRB 796-treated SM. CTB transported from the left eye (LE, green) and the right eye (RE, red) are shown. Scale: 500 μm. (f) Scatter plot showing percent intact transport to the LGN from microbead-injected eyes from vehicle- and BIRB 796-treated SMs. Thin black lines indicate mean ± SEM. Thick black dotted line indicates transport to the LGN from saline-injected eyes (Saline) from a previous study for non-statistical comparison39. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 4 eyes per group (a,b); n = 4 LGNs for vehicle-treated group and 4 LGNs for BIRB 796-treated group (e,f).CC BY · PubMed Central
Figure 8 BIRB 796 and RGC axon survival in squirrel monkey optic nerves following IOP elevation. (a) Representative image of SM optic nerve montage used to count RGC axons using AxonJ46. Red line indicates optic nerve area as measured using Fiji45. Scale: 250 μm. (b) Representative image from saline-injected SM optic nerve montage from a previous study39. Scale: 100 μm. (c) Representative images from vehicle- and BIRB 796-treated SM optic nerve montages. Degenerating axon profiles (arrowheads) and disorganized axon fascicle (asterisk) are shown. Scale: 100 μm. (d) Low magnification images of saline-injected SM optic nerve, vehicle-treated SM optic nerve and BIRB 796-treated SM optic nerve. Scale: 500 μm. (e) Scatter plot showing RGC axon number from vehicle- and BIRB 796-treated SM optic nerves. Thin black lines indicate mean ± SEM. Thick black dotted line indicates mean RGC axon number from saline-injected eyes (Saline) from a previous study for non-statistical comparison39. (f) Scatter plot showing area from vehicle- and BIRB 796-treated SM optic nerves. Thin black lines indicate mean ± SEM. Thick black dotted line indicates mean optic nerve axon area from saline-injected eyes (Saline) from a previous study for non-statistical comparison39. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 4 optic nerve montages for vehicle-treated and 4 optic nerve montages BIRB 796-treated groups.
Figure 8 BIRB 796 and RGC axon survival in squirrel monkey optic nerves following IOP elevation. (a) Representative image of SM optic nerve montage used to count RGC axons using AxonJ46. Red line indicates optic nerve area as measured using Fiji45. Scale: 250 μm. (b) Representative image from saline-injected SM optic nerve montage from a previous study39. Scale: 100 μm. (c) Representative images from vehicle- and BIRB 796-treated SM optic nerve montages. Degenerating axon profiles (arrowheads) and disorganized axon fascicle (asterisk) are shown. Scale: 100 μm. (d) Low magnification images of saline-injected SM optic nerve, vehicle-treated SM optic nerve and BIRB 796-treated SM optic nerve. Scale: 500 μm. (e) Scatter plot showing RGC axon number from vehicle- and BIRB 796-treated SM optic nerves. Thin black lines indicate mean ± SEM. Thick black dotted line indicates mean RGC axon number from saline-injected eyes (Saline) from a previous study for non-statistical comparison39. (f) Scatter plot showing area from vehicle- and BIRB 796-treated SM optic nerves. Thin black lines indicate mean ± SEM. Thick black dotted line indicates mean optic nerve axon area from saline-injected eyes (Saline) from a previous study for non-statistical comparison39. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 4 optic nerve montages for vehicle-treated and 4 optic nerve montages BIRB 796-treated groups.CC BY · PubMed Central
Figure 9 BIRB 796 detected in SM vitreous and attenuated activation of p38 MAPK pathway members in SM retinas. (a) Relative abundance of BIRB 796 and reference standard ML-297 in vitreous samples measured by liquid chromatography–mass spectrometry (LC-MS). (b) Scatter plot showing LC-MS measurements of BIRB 796 concentration (μM) in SM vitreous samples with known concentrations of BIRB 796 added. (b’) shows nM range of BIRB 796 concentrations applied. (c) Bar graph showing LC-MS measurement of BIRB 796 in SM vitreous following topical delivery of 3% BIRB 796 (40 μl/day) to cornea for one week, or two intravitreal injections of 0.75% BIRB 796 (40 μl) one week apart. Last topical dose and last intraviteal injection given just prior to vitreous sampling. (d) Scatter plot showing LC-MS measurements of BIRB 796 concentration (μM) in SM vitreous samples following topical delivery of 3% BIRB 796 (40 μl/day) to cornea for 9 weeks. Vitreous sampled every 3 weeks. (e) Confocal images from vehicle- and BIRB 796-treated SM retina showing immunolabeling for phosphorylated p38 MAPK (pp38; red). CTB uptake (green) by RGCs is shown. Dotted lines indicate region where label was quantified. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. Scale bars: 30 μm. (f) Confocal images from vehicle- and BIRB 796-treated SM retina showing immunolabeling for phosphorylated MK2 (pMK2; red). CTB uptake (green) by RGCs is shown. Dotted lines indicate region where label was quantified. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (g) Confocal images from vehicle- and BIRB 796-treated SM retina showing immunolabeling for phosphorylated heat shock protein 27 (pHSP27; red). CTB uptake (green) by RGCs is shown. Dotted lines indicate region where label was quantified. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (h) Scatter plot showing percent area of vehicle- and BIRB 796-treated SM retinas immunolabeled for phosphorylated p38 MAPK (pp38). Thin black lines indicate mean ± SEM. (i) Scatter plot showing percent area of vehicle- and BIRB 796-treated SM retinas immunolabeled for phosphorylated MK2 (pMK2). Thin black lines indicate mean ± SEM. *p = 0.04. (j) Scatter plot showing percent area of vehicle- and BIRB 796-treated SM retinas immunolabeled for phosphorylated heat shock protein 27 (pHSP27). Thin black lines indicate mean ± SEM. *p = 0.03. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 6 SM eyes for naïve, 1 SM eye for topical and 1 SM eye for intravitreal (c); n = 2 SM eyes (d); n = 4 eyes for vehicle-treated and 4 eyes for BIRB 796-treated groups (e–j).
Figure 9 BIRB 796 detected in SM vitreous and attenuated activation of p38 MAPK pathway members in SM retinas. (a) Relative abundance of BIRB 796 and reference standard ML-297 in vitreous samples measured by liquid chromatography–mass spectrometry (LC-MS). (b) Scatter plot showing LC-MS measurements of BIRB 796 concentration (μM) in SM vitreous samples with known concentrations of BIRB 796 added. (b’) shows nM range of BIRB 796 concentrations applied. (c) Bar graph showing LC-MS measurement of BIRB 796 in SM vitreous following topical delivery of 3% BIRB 796 (40 μl/day) to cornea for one week, or two intravitreal injections of 0.75% BIRB 796 (40 μl) one week apart. Last topical dose and last intraviteal injection given just prior to vitreous sampling. (d) Scatter plot showing LC-MS measurements of BIRB 796 concentration (μM) in SM vitreous samples following topical delivery of 3% BIRB 796 (40 μl/day) to cornea for 9 weeks. Vitreous sampled every 3 weeks. (e) Confocal images from vehicle- and BIRB 796-treated SM retina showing immunolabeling for phosphorylated p38 MAPK (pp38; red). CTB uptake (green) by RGCs is shown. Dotted lines indicate region where label was quantified. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. Scale bars: 30 μm. (f) Confocal images from vehicle- and BIRB 796-treated SM retina showing immunolabeling for phosphorylated MK2 (pMK2; red). CTB uptake (green) by RGCs is shown. Dotted lines indicate region where label was quantified. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (g) Confocal images from vehicle- and BIRB 796-treated SM retina showing immunolabeling for phosphorylated heat shock protein 27 (pHSP27; red). CTB uptake (green) by RGCs is shown. Dotted lines indicate region where label was quantified. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer. (h) Scatter plot showing percent area of vehicle- and BIRB 796-treated SM retinas immunolabeled for phosphorylated p38 MAPK (pp38). Thin black lines indicate mean ± SEM. (i) Scatter plot showing percent area of vehicle- and BIRB 796-treated SM retinas immunolabeled for phosphorylated MK2 (pMK2). Thin black lines indicate mean ± SEM. *p = 0.04. (j) Scatter plot showing percent area of vehicle- and BIRB 796-treated SM retinas immunolabeled for phosphorylated heat shock protein 27 (pHSP27). Thin black lines indicate mean ± SEM. *p = 0.03. Data expressed as mean ± SEM. Statistical comparisons made using two-sided t-tests. n = 6 SM eyes for naïve, 1 SM eye for topical and 1 SM eye for intravitreal (c); n = 2 SM eyes (d); n = 4 eyes for vehicle-treated and 4 eyes for BIRB 796-treated groups (e–j).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Cited by

See all 21

Metadata

Authors
Lambert, W. S., Pasini, S., Collyer, J. W., Formichella, C. R., Ghose, P., Carlson, B. J., & Calkins, D. J.
Affiliations
Vanderbilt University Medical Center (US)
Corresponding author
Calkins, David J.
Venue
Scientific Reports
Published
2020-05-22
Volume
10
Issue
1
Pages
8535-8535
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3027976236
Cited by
21
References
89
Citations by year
2026: 1 · 2025: 5 · 2024: 1 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 2
FWCI
2.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Glaucoma Research Foundation
  • Research to Prevent Blindness
  • Vanderbilt University (DK59637, DK20593, DK58404, CA68485, EY08126)
  • National Institutes of Health (DK-59637, EY08126, CA68485, DK 20593, DK-58404, CA68485, DK20593, DK58404, DK59637 and EY08126)
  • Vanderbilt Vision Research Center, Vanderbilt University (P30 EY-08126)
  • National Eye Institute (R01EY017427, R01EY024997, P30EY008126)
  • National Cancer Institute (P30CA068485)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK059637, P30DK058404, P30DK020593)
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
glaucoma, p38 MAPK inhibition, BIRB-796, neuroprotection, retinal ganglion cell death, axonal transport, superior colliculus, optic nerve degeneration, intraocular pressure elevation, treatment duration, optic neuropathy
MeSH terms
Animals, Axonal Transport, Disease Models, Animal, Glaucoma, Intraocular Pressure, Male, Mice, Inbred DBA, Naphthalenes, Optic Nerve, Phenylurea Compounds, Pyrazoles, Retinal Ganglion Cells, Saimiri, Neuroprotective Agents, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma. https://app.cochat.ai/papers/10.1038/s41598-020-65374-6
The paper
Lambert, W. S., Pasini, S., Collyer, J. W., Formichella, C. R., Ghose, P., Carlson, B. J., & Calkins, D. J. (2020). Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma. Scientific Reports. https://doi.org/10.1038/s41598-020-65374-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.